A detailed history of Peninsula Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Peninsula Asset Management Inc holds 28,937 shares of ABT stock, worth $3.41 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares
28,937
Previous 29,165 0.78%
Holding current value
$3.41 Million
Previous $3.03 Million 8.88%
% of portfolio
1.68%
Previous 1.69%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $22,815 - $26,933
-228 Reduced 0.78%
28,937 $3.3 Million
Q2 2024

Aug 12, 2024

SELL
$100.73 - $112.44 $12,591 - $14,055
-125 Reduced 0.43%
29,165 $3.03 Million
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $8,214 - $9,072
-75 Reduced 0.26%
29,290 $3.33 Million
Q4 2023

Feb 07, 2024

SELL
$90.19 - $110.4 $16,685 - $20,424
-185 Reduced 0.63%
29,365 $3.23 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $45,376 - $54,444
-475 Reduced 1.58%
29,550 $2.86 Million
Q2 2023

Aug 04, 2023

SELL
$100.78 - $112.29 $33,257 - $37,055
-330 Reduced 1.09%
30,025 $3.27 Million
Q1 2023

May 05, 2023

SELL
$96.86 - $114.01 $55,694 - $65,555
-575 Reduced 1.86%
30,355 $3.07 Million
Q4 2022

Feb 15, 2023

SELL
$95.06 - $111.52 $121,676 - $142,745
-1,280 Reduced 3.97%
30,930 $3.4 Million
Q3 2022

Nov 15, 2022

SELL
$96.76 - $112.03 $5,321 - $6,161
-55 Reduced 0.17%
32,210 $3.12 Million
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $108,704 - $131,389
-1,065 Reduced 3.2%
32,265 $3.51 Million
Q1 2022

May 10, 2022

BUY
$114.02 - $139.04 $3,990 - $4,866
35 Added 0.11%
33,330 $3.94 Million
Q4 2021

Feb 15, 2022

SELL
$115.53 - $141.46 $56,725 - $69,456
-491 Reduced 1.45%
33,295 $4.69 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $131,359 - $145,321
1,126 Added 3.45%
33,786 $3.99 Million
Q2 2021

Aug 04, 2021

SELL
$105.79 - $124.53 $18,090 - $21,294
-171 Reduced 0.52%
32,660 $3.79 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $101,330 - $119,382
931 Added 2.92%
32,831 $3.94 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $14,175 - $15,446
135 Added 0.42%
31,900 $3.49 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $38,488 - $46,741
-420 Reduced 1.3%
31,765 $3.46 Million
Q2 2020

Aug 10, 2020

SELL
$76.57 - $98.0 $55,589 - $71,148
-726 Reduced 2.21%
32,185 $2.94 Million
Q1 2020

May 21, 2020

BUY
$62.82 - $91.86 $216,163 - $316,090
3,441 Added 11.68%
32,911 $2.6 Million
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $49,068 - $54,625
625 Added 2.17%
29,470 $2.56 Million
Q3 2019

Nov 15, 2019

BUY
$81.84 - $88.74 $51,968 - $56,349
635 Added 2.25%
28,845 $2.41 Million
Q2 2019

Aug 15, 2019

BUY
$72.88 - $85.0 $68,142 - $79,475
935 Added 3.43%
28,210 $2.37 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $1.81 Million - $2.18 Million
27,275 New
27,275 $2.18 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Peninsula Asset Management Inc Portfolio

Follow Peninsula Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peninsula Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Peninsula Asset Management Inc with notifications on news.